Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Tine Bichel Lauritsen"'
Autor:
Tine Bichel Lauritsen, Lene Sofie Granfeldt Østgård, Kirsten Grønbæk, Susanne Oksbjerg Dalton, Jan Maxwell Nørgaard
Publikováno v:
Lauritsen, T B, Østgård, L S G, Grønbæk, K, Dalton, S O & Nørgaard, J M 2022, ' Socioeconomic position and clinical outcomes in patients with myelodysplastic syndromes : A population-based cohort study ', Hematological Oncology, vol. 40, no. 5, pp. 1056-1066 . https://doi.org/10.1002/hon.3068
Low socioeconomic position (SEP) may be associated with adverse outcomes in patients with myelodysplastic syndromes (MDS) inherent to for example, delayed diagnosis or reduced treatment intensity, but firm evidence is limited. In this study, we exami
Autor:
Tine Bichel Lauritsen, Jan Maxwell Nørgaard, Mathilde Egelund Christensen, Susanne Oksbjerg Dalton, Lene Sofie Granfeldt Østgård
Publikováno v:
Lauritsen, T B, Norgaard, J M, Christensen, M E, Dalton, S O & Ostgard, L S G 2022, ' Positive predictive values of hematological procedure codes in the Danish National Patient Registry-A population-based validation study ', Pharmacoepidemiology and Drug Safety, vol. 31, no. 9, pp. 963-971 . https://doi.org/10.1002/pds.5485
Lauritsen, T B, Nørgaard, J M, Christensen, M E, Dalton, S O & Østgård, L S G 2022, ' Positive predictive values of hematological procedure codes in the Danish National Patient Registry—A population-based validation study ', Pharmacoepidemiology and Drug Safety, vol. 31, no. 9, pp. 963-971 . https://doi.org/10.1002/pds.5485
Lauritsen, T B, Nørgaard, J M, Christensen, M E, Dalton, S O & Østgård, L S G 2022, ' Positive predictive values of hematological procedure codes in the Danish National Patient Registry—A population-based validation study ', Pharmacoepidemiology and Drug Safety, vol. 31, no. 9, pp. 963-971 . https://doi.org/10.1002/pds.5485
Background: The Danish National Patient Registry holds data on hematological procedure codes including date and type of treatment from all hematological departments in Denmark. The validity of the hematological procedure codes remains to be clarified
Autor:
Lene Sofie Granfeldt Østgård, Tine Bichel Lauritsen, Syed Azhar Ahmad, Marianne Tang Severinsen, Kirsten Grønbæk, Kasper Adelborg, Jan Maxwell Nørgaard, Louise Hur Hannig, Anders Pommer Vallentin
Publikováno v:
Lauritsen, T B, Nørgaard, J M, Grønbæk, K, Vallentin, A P, Ahmad, S A, Hannig, L H, Severinsen, M T, Adelborg, K & Østgård, L S G 2021, ' The Danish Myelodysplastic Syndromes Database : Patient Characteristics and Validity of Data Records ', Clinical Epidemiology, vol. 13, pp. 439-451 . https://doi.org/10.2147/CLEP.S306857
Clinical Epidemiology
Clinical Epidemiology
Tine Bichel Lauritsen,1 Jan Maxwell Nørgaard,1 Kirsten Grønbæk,2– 4 Anders Pommer Vallentin,5 Syed Azhar Ahmad,6 Louise Hur Hannig,7 Marianne Tang Severinsen,8,9 Kasper Adelborg,10,11 Lene Sofie Granfeldt Østgård11,12 1Department of Hematology
Autor:
Jan Maxwell Nørgaard, Susanne Oksbjerg Dalton, Kirsten Groenbaek, Tine Bichel Lauritsen, Lene Sofie Granfeldt Oestgaard
Publikováno v:
Blood. 138:4670-4670
Background: Five-year overall survival for patients with myelodysplastic syndromes (MDS) is around 30%. Adverse prognostic factors include advancing age, higher blast cell percentage, poor risk cytogenetics, two or more cytopenias, high burden of com